Quarterly Transactions Made in Spero Therapeutics, Inc. (SPRO)
This table provides information about the institutional ownership of Spero Therapeutics, Inc. (SPRO). The information is specifically focused on institutions that hold shares of Spero Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,295,106 | 592,426 | 1,887,532 | 563,349 | 36,233 | 599,582 | 1,287,950 | |
| Q4 2021 | 729,539 | 1,345,258 | 2,074,797 | 515,144 | 110,792 | 625,936 | 1,448,861 | |
| Q1 2022 | 737,878 | 700,566 | 1,438,444 | 1,009,504 | 53,626 | 1,063,130 | 375,314 | |
| Q2 2022 | 4,440,152 | 1,143,275 | 5,583,427 | 2,619,633 | 1,771,107 | 4,390,740 | 1,192,687 | |
| Q3 2022 | 650,530 | 4,925,832 | 5,576,362 | 5,094,411 | 1,934 | 5,096,345 | 480,017 | |
| Q4 2022 | 1,929,809 | 542,415 | 2,472,224 | 1,580,709 | 0 | 1,580,709 | 891,515 | |
| Q1 2023 | 1,037,015 | 109,800 | 1,146,815 | 679,159 | 0 | 679,159 | 467,656 | |
| Q2 2023 | 547,627 | 823,905 | 1,371,532 | 1,174,955 | 300 | 1,175,255 | 196,277 | |
| Q3 2023 | 1,015,556 | 34,706 | 1,050,262 | 954,872 | 0 | 954,872 | 95,390 | |
| Q4 2023 | 361,165 | 1,141,830 | 1,502,995 | 355,392 | 0 | 355,392 | 1,147,603 | |
| Q1 2024 | 894,763 | 712,920 | 1,607,683 | 1,204,628 | 0 | 1,204,628 | 403,055 | |
| Q2 2024 | 583,020 | 406,986 | 990,006 | 561,664 | 0 | 561,664 | 428,342 | |
| Q3 2024 | 38,690 | 27,830 | 66,520 | 661,507 | 0 | 661,507 | -594,987 | |